497 related articles for article (PubMed ID: 32335998)
1. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
[TBL] [Abstract][Full Text] [Related]
2. Hsa_circRNA_0059655 plays a role in salivary adenoid cystic carcinoma by functioning as a sponge of miR-338-3p.
Zhao F; Chen CW; Yang WW; Xu LH; Du ZH; Ge XY; Li SL
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):100-106. PubMed ID: 30672444
[TBL] [Abstract][Full Text] [Related]
3. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
4. SOX2-Induced Linc-ROR Upregulation Inhibits Gastric Carcinoma Cell Proliferation and Metastasis Via the miR-580-3p/ANXA10 Pathway.
Bai L; Zhuang Y; Xie J; Liu K; Yin S; Yan F
Biochem Genet; 2023 Jun; 61(3):1113-1127. PubMed ID: 36451051
[TBL] [Abstract][Full Text] [Related]
5. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.
Liu L; Li Y; Zhang R; Li C; Xiong J; Wei Y
BMC Pulm Med; 2020 Jun; 20(1):163. PubMed ID: 32513149
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis.
Xu Y; Zhang G; Zou C; Zhang H; Gong Z; Wang W; Ma G; Jiang P; Zhang W
Cell Physiol Biochem; 2018; 46(6):2445-2459. PubMed ID: 29742512
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA HCG9 Promotes Osteosarcoma Progression through RAD51 by Acting as a ceRNA of miR-34b-3p.
Wang L; Li S; Qi L; Ling L
Mediators Inflamm; 2021; 2021():9978882. PubMed ID: 34456631
[TBL] [Abstract][Full Text] [Related]
8. Lnc-PSMA8-1 activated by GEFT promotes rhabdomyosarcoma progression via upregulation of mTOR expression by sponging miR-144-3p.
Meng L; Shang H; Liu Q; Li Z; Wang X; Li Q; Li F; Zhao Z; Liu C
BMC Cancer; 2024 Jan; 24(1):79. PubMed ID: 38225540
[TBL] [Abstract][Full Text] [Related]
9. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
10. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis.
Hou P; Zhao Y; Li Z; Yao R; Ma M; Gao Y; Zhao L; Zhang Y; Huang B; Lu J
Cell Death Dis; 2014 Jun; 5(6):e1287. PubMed ID: 24922071
[TBL] [Abstract][Full Text] [Related]
11. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
[TBL] [Abstract][Full Text] [Related]
12. Linc-ROR targets FGF2 to regulate HASMC proliferation and migration via sponging miR-195-5p.
Ji Z; Chi J; Sun H; Ru A; Ni T; Zhang J; Jiang F; Lv H; Peng F; Guo H; Chen Y
Gene; 2020 Jan; 725():144143. PubMed ID: 31629816
[TBL] [Abstract][Full Text] [Related]
13. Linc-ROR regulates apoptosis in esophageal squamous cell carcinoma via modulation of p53 ubiquitination by targeting miR-204-5p/MDM2.
Gao H; Wang T; Zhang P; Shang M; Gao Z; Yang F; Liu R
J Cell Physiol; 2020 Mar; 235(3):2325-2335. PubMed ID: 31541467
[TBL] [Abstract][Full Text] [Related]
14. Linc-ROR Promotes EMT by Targeting miR-204-5p/SMAD4 in Endometriosis.
Yi M; Wang S; Zhang X; Jiang L; Xia X; Zhang T; Fang X
Reprod Sci; 2023 Sep; 30(9):2665-2679. PubMed ID: 36917423
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
16. Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145.
Zhou X; Gao Q; Wang J; Zhang X; Liu K; Duan Z
Gynecol Oncol; 2014 May; 133(2):333-9. PubMed ID: 24589415
[TBL] [Abstract][Full Text] [Related]
17. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
Peng WX; Huang JG; Yang L; Gong AH; Mo YY
Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
19. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA anti-differentiation non-coding RNA affects proliferation, invasion, and migration of breast cancer cells by targeting miR-331.
Jiang C; Shi X; Yi D; Wang R; Xu F; Guan W; Sang J
Bioengineered; 2021 Dec; 12(2):12236-12245. PubMed ID: 34783641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
